122 results
Page 4 of 7
8-K
EX-99.1
nsx2o qypzw8c9xiqtc
30 Jul 20
Other Events
12:00am
8-K
EX-99.1
pfo53
11 May 20
Recro Reports First Quarter 2020 Financial Results and Provides Update onCOVID-19 Response and Impact
7:31am
DEFA14A
19gsra gnuvq3
1 May 20
Additional proxy soliciting materials
4:57pm
8-K
EX-99.1
ujobrj
4 Mar 20
Recro Reports Financial Results for the Year Ended 2019
7:00am
8-K
EX-2.1
7am5owfd u0
26 Nov 19
Entry into a Material Definitive Agreement
4:54pm
8-K
EX-99.2
esc4b 0gyu60vle5z
13 Nov 19
Other Events
7:16am
8-K
EX-99.1
687qx9 j6
8 Nov 19
Recro Pharma Reports Third Quarter 2019 Financial Results
7:05am
8-K
EX-99.1
9sjkvj75
5 Nov 19
Recro Pharma’s Board of Directors Approves Separation of Acute
7:07am
8-K
EX-99.1
yokrn
31 Oct 19
Other Events
10:10am
8-K
EX-99.1
wppdmvzcu c2ijr
8 Aug 19
Recro Pharma Reports Second Quarter 2019 Financial Results
7:58am
8-K
EX-99.1
lbg7o2udzg4td fi
10 May 19
Recro Pharma Reports First Quarter 2019 Financial Results
7:05am
8-K
EX-99.1
e2sy13kmjavkknq
5 Apr 19
Cost Associated with Exit or Disposal Activities
4:01pm
8-K
EX-99.1
zvoapui6sinokrh d6x1
28 Mar 19
Recro Pharma Appoints Arnaud Ajdler to Its Board of Directors
6:05am
8-K
EX-99.1
4jla0 ihg
22 Mar 19
Recro Pharma Receives Complete Response Letter from the FDA for Intravenous Meloxicam
4:17pm